- American City Business Journals•17 days ago
At the beginning of 2015, Durham’s Heat Biologics (HTBX) announced a collaboration with San Diego-based biotechnology company OncoSec Medical Incorporated (ONCS). The companies announced this week that the collaboration – which is aimed at evaluating the delivery of immunotherapy vaccines being developed by Heat using OncoSec’s ImmunoPulse platform – is showing promise based on new preclinical data.
- TheStreet.com•18 days ago
An SEC enforcement action uncovers the deep involvement and brazen misbehavior of biotech CEOs in an illegal stock promotion scheme.
- GlobeNewswire•24 days ago
Heat Biologics Presents New Preclinical Data from OncoSec Collaboration at the American Association for Cancer Research (AACR) Annual Meeting
Combining ComPACT DNA electroporation and cellular vaccination led to increased tumor antigen-specific CD8+ T cells, delayed tumor progression and improved overall survival in preclinical models. Demonstrates ...
ONCS : Summary for OncoSec Medical Incorporated - Yahoo Finance
OncoSec Medical Incorporated (ONCS)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||1.08 x 1000|
|Ask||1.50 x 300|
|Day's Range||1.13 - 1.17|
|52 Week Range||1.03 - 2.08|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.88|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|